138 related articles for article (PubMed ID: 34381416)
1. Gait Speed Trajectory During the Six-Minute Walk Test in Multiple Sclerosis: A Measure of Walking Endurance.
Chen S; Sierra S; Shin Y; Goldman MD
Front Neurol; 2021; 12():698599. PubMed ID: 34381416
[No Abstract] [Full Text] [Related]
2. Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance.
Cederberg KLJ; Sikes EM; Bartolucci AA; Motl RW
Gait Posture; 2019 Sep; 73():147-153. PubMed ID: 31326830
[TBL] [Abstract][Full Text] [Related]
3. Six-Minute Walk as a Measure of Walking Capacity and Endurance in Patients With Pediatric-Onset Multiple Sclerosis.
Brenton JN; Florenzo B; Koshiya H; Min S; Woolbright E; Coleman R; Chen S; Goldman M
Neurology; 2022 Nov; 99(19):e2161-e2170. PubMed ID: 35985830
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
Goldman MD; Marrie RA; Cohen JA
Mult Scler; 2008 Apr; 14(3):383-90. PubMed ID: 17942508
[TBL] [Abstract][Full Text] [Related]
5. Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test.
Adonis A; Taylor GP
PLoS One; 2016; 11(6):e0157132. PubMed ID: 27336911
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Motl RW; Balantrapu S; Pilutti L; Dlugonski D; Suh Y; Sandroff BM; Lane A; Fernhall B
Eur J Phys Rehabil Med; 2013 Feb; 49(1):59-66. PubMed ID: 22820825
[TBL] [Abstract][Full Text] [Related]
7. Quantifying six-minute walk induced gait deterioration with inertial sensors in multiple sclerosis subjects.
Engelhard MM; Dandu SR; Patek SD; Lach JC; Goldman MD
Gait Posture; 2016 Sep; 49():340-345. PubMed ID: 27479220
[TBL] [Abstract][Full Text] [Related]
8. Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
Sandroff BM; Pilutti LA; Motl RW
NeuroRehabilitation; 2015; 37(1):149-55. PubMed ID: 26409700
[TBL] [Abstract][Full Text] [Related]
9. Progression risk stratification with six-minute walk gait speed trajectory in multiple sclerosis.
Goldman MD; Chen S; Motl R; Pearsall R; Oh U; Brenton JN
Front Neurol; 2023; 14():1259413. PubMed ID: 37859654
[TBL] [Abstract][Full Text] [Related]
10. An exploration of impaired walking dynamics and fatigue in multiple sclerosis.
Burschka JM; Keune PM; Menge U; Hofstadt-van Oy U; Oschmann P; Hoos O
BMC Neurol; 2012 Dec; 12():161. PubMed ID: 23270547
[TBL] [Abstract][Full Text] [Related]
11. Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.
Applebee A; Goodman AD; Mayadev AS; Bethoux F; Goldman MD; Klingler M; Blight AR; Carrazana EJ
Clin Ther; 2015 Dec; 37(12):2780-7. PubMed ID: 26565077
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis.
Motl RW; Suh Y; Balantrapu S; Sandroff BM; Sosnoff JJ; Pula J; Goldman MD; Fernhall B
BMC Neurol; 2012 Mar; 12():6. PubMed ID: 22380843
[TBL] [Abstract][Full Text] [Related]
13. Examination of spatiotemporal gait parameters during the 6-min walk in individuals with multiple sclerosis.
Socie MJ; Motl RW; Sosnoff JJ
Int J Rehabil Res; 2014 Dec; 37(4):311-6. PubMed ID: 25117855
[TBL] [Abstract][Full Text] [Related]
14. Validity and reliability of the 6 minute walk in persons with fibromyalgia.
King S; Wessel J; Bhambhani Y; Maikala R; Sholter D; Maksymowych W
J Rheumatol; 1999 Oct; 26(10):2233-7. PubMed ID: 10529146
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of StepWatch™ and ActiGraph accelerometers for measuring steps taken among persons with multiple sclerosis.
Sandroff BM; Motl RW; Pilutti LA; Learmonth YC; Ensari I; Dlugonski D; Klaren RE; Balantrapu S; Riskin BJ
PLoS One; 2014; 9(4):e93511. PubMed ID: 24714028
[TBL] [Abstract][Full Text] [Related]
16. The endurance shuttle walking test: a responsive measure in pulmonary rehabilitation for COPD patients.
Eaton T; Young P; Nicol K; Kolbe J
Chron Respir Dis; 2006; 3(1):3-9. PubMed ID: 16509172
[TBL] [Abstract][Full Text] [Related]
17. Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis.
Sandroff BM; Motl RW; Román CAF; Wylie GR; DeLuca J; Cutter GR; Benedict RHB; Dwyer MG; Zivadinov R
J Neurol; 2022 Oct; 269(10):5531-5540. PubMed ID: 35718819
[TBL] [Abstract][Full Text] [Related]
18. Assessment of walking speed and distance in subjects with an incomplete spinal cord injury.
van Hedel HJ; Dietz V; Curt A
Neurorehabil Neural Repair; 2007; 21(4):295-301. PubMed ID: 17353459
[TBL] [Abstract][Full Text] [Related]
19. Relationship between gait variables and domains of neurologic dysfunction in multiple sclerosis using six-minute walk test.
Qureshi A; Brandt-Pearce M; Goldman MD
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():4959-4962. PubMed ID: 28269381
[TBL] [Abstract][Full Text] [Related]
20. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds.
Steffen TM; Hacker TA; Mollinger L
Phys Ther; 2002 Feb; 82(2):128-37. PubMed ID: 11856064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
